When deciding to perform a quantitative proteomics analysis, selectivity, sensitivity, and reproducibility are important criteria to consider. The use of multiple reaction monitoring (MRM) has emerged as a powerful proteomics technique in that regard since it avoids many of the problems typically observed in discovery-based analyses. A prerequisite for such a targeted approach is that the protein targets are known, either as a result of previous global proteomics experiments or because a specific hypothesis is to be tested. When guidelines that have been established in the pharmaceutical industry many decades ago are taken into account, setting up an MRM assay is relatively straightforward. Typically, proteotypic peptides with favorable mass spectrometric properties are synthesized with a heavy isotope for each protein that is to be monitored. Retention times and calibration curves are determined using triple-quadrupole mass spectrometers. The use of iRT peptide standards is both recommended and fully integrated into the bioinformatics pipeline. Digested biological samples are mixed with the heavy and iRT standards and quantified. Here we present a generic protocol for the development of an MRM assay.
MRM Quadrupole mass spectrometry Quantitation
Springer Nature is developing a new tool to find and evaluate Protocols. Learn more
Hess S, Akermann M, Ropte D et al (2001) Rapid and sensitive LC separation of new impurities in trimethoprim. J Pharm Biomed Anal 25(3–4):531–538CrossRefPubMedGoogle Scholar
Hess S, Dolker M, Haferburg D et al (2001) Separation, analyses and syntheses of trimethoprim impurities. Pharmazie 56(4):306–310PubMedGoogle Scholar
Hess S, Muller CE, Frobenius W et al (2000) 7-deazaadenines bearing polar substituents: structure-activity relationships of new A(1) and A(3) adenosine receptor antagonists. J Med Chem 43(24):4636–4646. doi:10.1021/Jm000967dCrossRefPubMedGoogle Scholar
Hess S, Teubert U, Ortwein J et al (2001) Profiling indomethacin impurities using high-performance liquid chromatography and nuclear magnetic resonance. Eur J Pharm Sci 14(4):301–311CrossRefPubMedGoogle Scholar